| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| October 31st, 2005 | 24 | Yes |
Popular Name: Naloxone hydrochloride Naloxone hydrochloride
Find On: PubMed — Wikipedia — Google
CAS Numbers: 357-08-4 , 357-08-4, 51481-60-8 [dih , 357-08-4, 51481-60-8 [dihydrate], 465-65-6 [naloxone] , 408365-87-7 , 465-65-6 , 51481-60-8 , [357-08-4] , [51481-60-8]
(-)-N-allyl-14-hydroxynordihydroxymorphinan-6-one
(5alpha)-17-Allyl-3,14-dihydroxy-4,5-epoxymorphinan-6-one hydrochloride dihydrate
(5alpha)-3,14-dihydroxy-17-prop-2-en-1-yl-4,5-epoxymorphinan-6-one
(5alpha)-4,5-Epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one
1-N-Allyl-14-hydroxynordihydromorphinone
1-N-Allyl-7,8-dihydro-14-hydroxynormorphinone
12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro(4,5-bcd)furanone
12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro[4,5-bcd]furan-5(6H)-one
17-allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one
17-Allyl-4,5-alpha-epoxy-3,14-dihydroxymorphinan-6-one
17-Allyl-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one
3,14-dihydroxy-17-(prop-2-en-1-yl)-4,5alpha-epoxymorphinan-6-one
357-08-4; D01340; Naloxone hydrochloride (JP16/USP); Narcan (TN)
357-08-4; Naloxone hydrochloride; Prestwick_879
465-65-6; D08249; DBL Naloxone (TN); Naloxone (INN)
4aH-8,9c-Iminoethanophenanthro[4,5-bcd]furan-5(6H)-one, N-allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-
CPD000058766; NALOXONE HYDROCHLORIDE; SAM002703137
ethyl 2-(6-(tert-butoxycarbonyl)pyridin-2-yl)acetate
INN); Naloxone Hydrochloride (FDA
l-N-Allyl-14-hydroxynordihydromorphinone
l-N-Allyl-7,8-dihydro-14-hydroxynormorphinone
Morphinan-6-one, 17-allyl-4,5.alpha.-epoxy-3,14-dihydroxy-
Morphinan-6-one, 17-allyl-4,5alpha-epoxy-3,14-dihydroxy-
Morphinan-6-one, 17-allyl-4,5alpha-epoxy-3,14-dihydroxy- (8CI)
Morphinan-6-one, 4,5-alpha-epoxy-3,14-dihydroxy-17-(2-propenyl)-
Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5.alpha.)-
Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5alpha)-
Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5alpha)- (9CI)
Morphinan-6-one, 4,5.alpha.-epoxy-3,14-dihydroxy-17-(2-propenyl)-
Morphinan-6-one, 4,5alpha-epoxy-3,14-dihydroxy-17-(2-propenyl)-
N-Allyl-4,5alpha-epoxy-3,14-dihydroxy-6-morphinanon
Naloxone hydrochloride dihydrate
Naloxone hydrochloride dihydrate, 98%+
Normorphinone, N-allyl-7,8-dihydro-14-hydroxy-, (-)-
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 1.12 | 3.75 | -57.02 | 3 | 5 | 1 | 71 | 328.388 | 2 | ↓ |
| Hi High (pH 8-9.5) | 1.12 | 1.61 | -13.48 | 2 | 5 | 0 | 70 | 327.38 | 2 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| ALOGPS_SOLUBILITY | 5.64e+00 g/l | DrugBank-approved |
| UniProt Database Links | CXAG_NAJAT; MORA_PSEPU; NXSM1_DENPO; NXSM2_DENPO; PA2H_GLOUS | ChEBI |
| PUBCHEM_PATENT_ID | EP0144341A1; EP0170090A1; EP0238507A1; EP0250796A2; US4089855; US4496570; US4619936; US4668685; US4673679; US4722928; US4760069; US4912109; US4916142; US4954506; US4990617; US5071985; US5760044; US5866154; US5965567; WO1999003347A1 | IBM Patent Data |
| Patent Database Links | EP1535615; EP1557179; EP1584335; EP1600160; EP1604666; EP1604667; EP1639997; EP1681057; EP1685839; EP1695700; EP1702627; EP1767221; EP1785145; EP1813276; EP1813283; EP1815846; EP1820805; EP1829527; EP1829528; EP1849460; EP1870096; EP1894562; EP1897543; EP | ChEBI |
| Therapy | narcotic antagonist | SMDC MicroSource |
| PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : MZ-3032; NCC_SUPPLIER_SAMPLE_COMMENTS : WHITE POWDER; 1 hydrogen chloride | NIH Clinical Collection via PubChem |
| Target | Opioid Receptor | Selleck Chemicals |
| PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: MZ-3032; SALT: 1 hydrogen chloride; SUPPLIER_COMMENTS: WHITE POWDER | NIH Clinical Collection via PubChem |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| AA3R-1-E | Adenosine Receptor A3 (cluster #1 Of 6), Eukaryotic | Eukaryotes | 2 | 0.51 | Binding ≤ 10μM |
| CCR5-1-E | C-C Chemokine Receptor Type 5 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 21 | 0.45 | Binding ≤ 10μM |
| OPRD-1-E | Delta Opioid Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 76 | 0.42 | Binding ≤ 10μM |
| OPRK-1-E | Kappa Opioid Receptor (cluster #1 Of 6), Eukaryotic | Eukaryotes | 9 | 0.47 | Binding ≤ 10μM |
| OPRM-1-E | Mu-type Opioid Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 23 | 0.45 | Binding ≤ 10μM |
| SGMR1-1-E | Sigma Opioid Receptor (cluster #1 Of 6), Eukaryotic | Eukaryotes | 44 | 0.43 | Binding ≤ 10μM |
| OPRK-1-E | Kappa Opioid Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7 | 0.48 | Functional ≤ 10μM |
| Z50597-1-O | Rattus Norvegicus (cluster #1 Of 5), Other | Other | 6 | 0.48 | Binding ≤ 10μM |
| Z50597-1-O | Rattus Norvegicus (cluster #1 Of 12), Other | Other | 10 | 0.47 | Functional ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| AA3R_HUMAN | P33765 | Adenosine A3 Receptor, Human | 1.6 | 0.51 | Binding ≤ 1μM |
| CCR5_MOUSE | P51682 | C-C Chemokine Receptor Type 5, Mouse | 10.5 | 0.47 | Binding ≤ 1μM |
| OPRD_HUMAN | P41143 | Delta Opioid Receptor, Human | 120 | 0.40 | Binding ≤ 1μM |
| OPRD_RAT | P33533 | Delta Opioid Receptor, Rat | 0.1 | 0.58 | Binding ≤ 1μM |
| OPRK_CAVPO | P41144 | Kappa Opioid Receptor, Guinea Pig | 12 | 0.46 | Binding ≤ 1μM |
| OPRK_RAT | P34975 | Kappa Opioid Receptor, Rat | 0.1 | 0.58 | Binding ≤ 1μM |
| OPRK_HUMAN | P41145 | Kappa Opioid Receptor, Human | 0.25 | 0.56 | Binding ≤ 1μM |
| OPRM_HUMAN | P35372 | Mu Opioid Receptor, Human | 0.23 | 0.56 | Binding ≤ 1μM |
| OPRM_RAT | P33535 | Mu Opioid Receptor, Rat | 0.1 | 0.58 | Binding ≤ 1μM |
| OPRM_CAVPO | P97266 | Mu Opioid Receptor, Guinea Pig | 0.68 | 0.53 | Binding ≤ 1μM |
| OPRM_BOVIN | P79350 | Mu Opioid Receptor, Bovin | 5 | 0.48 | Binding ≤ 1μM |
| Z50597 | Z50597 | Rattus Norvegicus | 42 | 0.43 | Binding ≤ 1μM |
| SGMR1_RAT | Q9R0C9 | Sigma Opioid Receptor, Rat | 0.1 | 0.58 | Binding ≤ 1μM |
| SGMR1_HUMAN | Q99720 | Sigma Opioid Receptor, Human | 23 | 0.45 | Binding ≤ 1μM |
| AA3R_HUMAN | P33765 | Adenosine A3 Receptor, Human | 1.6 | 0.51 | Binding ≤ 10μM |
| CCR5_MOUSE | P51682 | C-C Chemokine Receptor Type 5, Mouse | 10.5 | 0.47 | Binding ≤ 10μM |
| OPRD_HUMAN | P41143 | Delta Opioid Receptor, Human | 120 | 0.40 | Binding ≤ 10μM |
| OPRD_RAT | P33533 | Delta Opioid Receptor, Rat | 0.1 | 0.58 | Binding ≤ 10μM |
| OPRK_HUMAN | P41145 | Kappa Opioid Receptor, Human | 0.25 | 0.56 | Binding ≤ 10μM |
| OPRK_CAVPO | P41144 | Kappa Opioid Receptor, Guinea Pig | 12 | 0.46 | Binding ≤ 10μM |
| OPRK_RAT | P34975 | Kappa Opioid Receptor, Rat | 0.1 | 0.58 | Binding ≤ 10μM |
| OPRM_CAVPO | P97266 | Mu Opioid Receptor, Guinea Pig | 0.68 | 0.53 | Binding ≤ 10μM |
| OPRM_BOVIN | P79350 | Mu Opioid Receptor, Bovin | 5 | 0.48 | Binding ≤ 10μM |
| OPRM_HUMAN | P35372 | Mu Opioid Receptor, Human | 0.23 | 0.56 | Binding ≤ 10μM |
| OPRM_RAT | P33535 | Mu Opioid Receptor, Rat | 0.1 | 0.58 | Binding ≤ 10μM |
| Z50597 | Z50597 | Rattus Norvegicus | 42 | 0.43 | Binding ≤ 10μM |
| SGMR1_RAT | Q9R0C9 | Sigma Opioid Receptor, Rat | 0.1 | 0.58 | Binding ≤ 10μM |
| SGMR1_HUMAN | Q99720 | Sigma Opioid Receptor, Human | 23 | 0.45 | Binding ≤ 10μM |
| OPRK_HUMAN | P41145 | Kappa Opioid Receptor, Human | 6.6 | 0.48 | Functional ≤ 10μM |
| Z50597 | Z50597 | Rattus Norvegicus | 10 | 0.47 | Functional ≤ 10μM |
| Description | Species |
|---|---|
| Adenosine P1 receptors | |
| Beta defensins | |
| Chemokine receptors bind chemokines | |
| G alpha (i) signalling events | |
| G-protein activation | |
| Opioid Signalling | |
| Peptide ligand-binding receptors |